These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

666 related items for PubMed ID: 18627416

  • 41. [Experimental basis for the treatment of drug-resistant epilepsy].
    Błaszczyk B, Trojnar M, Czuczwar SJ.
    Przegl Lek; 2006; 63(11):1221-3. PubMed ID: 17348421
    [Abstract] [Full Text] [Related]

  • 42. Measurement of seizure freedom in adjunctive therapy studies in refractory partial epilepsy: the levetiracetam experience.
    Leppik I, De Rue K, Edrich P, Perucca E.
    Epileptic Disord; 2006 Jun; 8(2):118-30. PubMed ID: 16793573
    [Abstract] [Full Text] [Related]

  • 43. Brivaracetam: Rationale for discovery and preclinical profile of a selective SV2A ligand for epilepsy treatment.
    Klitgaard H, Matagne A, Nicolas JM, Gillard M, Lamberty Y, De Ryck M, Kaminski RM, Leclercq K, Niespodziany I, Wolff C, Wood M, Hannestad J, Kervyn S, Kenda B.
    Epilepsia; 2016 Apr; 57(4):538-48. PubMed ID: 26920914
    [Abstract] [Full Text] [Related]

  • 44. Intravenous levetiracetam in children with epilepsy.
    Goraya JS, Khurana DS, Valencia I, Melvin JJ, Cruz M, Legido A, Kothare SV.
    Pediatr Neurol; 2008 Mar; 38(3):177-80. PubMed ID: 18279751
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. Remacemide--a novel potential antiepileptic drug.
    Małek R, Borowicz KK, Kimber-Trojnar Z, Sobieszek G, Piskorska B, Czuczwar SJ.
    Pol J Pharmacol; 2003 Mar; 55(5):691-8. PubMed ID: 14704464
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. Levetiracetam versus carbamazepine monotherapy for partial epilepsy in children less than 16 years of age.
    Perry S, Holt P, Benatar M.
    J Child Neurol; 2008 May; 23(5):515-9. PubMed ID: 18182645
    [Abstract] [Full Text] [Related]

  • 51. Comparison of the antiepileptogenic effects of an early long-term treatment with ethosuximide or levetiracetam in a genetic animal model of absence epilepsy.
    Russo E, Citraro R, Scicchitano F, De Fazio S, Di Paola ED, Constanti A, De Sarro G.
    Epilepsia; 2010 Aug; 51(8):1560-9. PubMed ID: 19919665
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. Anticonvulsant effects of levetiracetam and levetiracetam-diazepam combinations in experimental status epilepticus.
    Mazarati AM, Baldwin R, Klitgaard H, Matagne A, Wasterlain CG.
    Epilepsy Res; 2004 Feb; 58(2-3):167-74. PubMed ID: 15120747
    [Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. Levetiracetam: the profile of a novel anticonvulsant drug-part I: preclinical data.
    De Smedt T, Raedt R, Vonck K, Boon P.
    CNS Drug Rev; 2007 Feb; 13(1):43-56. PubMed ID: 17461889
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 34.